Vistin Pharma ASA: Mandatory notification of trade

Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma ASA at an average price of NOK 21,10 per share. Following this purchase Magnus Tolleshaug holds 105.000 shares in Vistin Pharma ASA.

Attachment

• Notification of trade_skjema - Magnus Tolleshaug

You May Also Be Interested In

• Invest In the USA (IIUSA) Submits Comprehensive Comments on DHS EB-5 Notice of Proposed Rulemaking
• Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Black Rock Coffee Bar Continues Expansion in California with New Lake Elsinore Location